Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10100066 Modulators of sestrin-GATOR2 interaction and uses thereof

Patent 10100066 was granted and assigned to Navitor Pharmaceuticals on October, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 8 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 8 Dec, 2023
Edits made to:
Article (+109 characters)
Article

Patent abstract

The present invention provides compounds, compositions thereof, and methods of using the same.

Edits on 1 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 1 Oct, 2023
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
David John O'Neill0
Eddine Saiah0
Kristina Michelle Fetalvero0
Shomit Sengupta0
Sridhar Narayan0
Edits on 12 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Jul, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11697633 Polymorphic compounds and uses thereof
0
Edits on 21 Jun, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Jun, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11679090 Modulators of Sestrin-GATOR2 interaction and uses thereof
0
Edits on 2 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Navitor Pharmaceuticals
Navitor Pharmaceuticals
0
Current Assignee
Navitor Pharmaceuticals
Navitor Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
101000660
Date of Patent
October 16, 2018
0
Patent Application Number
153313620
Date Filed
October 21, 2016
0
Patent Citations Received
‌
US Patent 11325924 Modulators of Sestrin-GATOR2 interaction and uses thereof
0
‌
US Patent 11345654 Polymorphic compounds and uses thereof
0
Patent Primary Examiner
‌
Po-Chih Chen
0
Edits on 29 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2023
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 24 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Edits on 1 Jun, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11345654 Polymorphic compounds and uses thereof
Edits on 19 May, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 May, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11325924 Modulators of Sestrin-GATOR2 interaction and uses thereof
Edits on 22 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 22 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10100066 Modulators of sestrin-GATOR2 interaction and uses thereof

Infobox
Is a
Patent
Patent
Patent applicant
Navitor Pharmaceuticals
Navitor Pharmaceuticals
Current assignee
Navitor Pharmaceuticals
Navitor Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10100066
Date of patent
October 16, 2018
Patent application number
15331362
Date Filed
October 21, 2016
Patent primary examiner
‌
Po-Chih Chen

Find more entities like US Patent 10100066 Modulators of sestrin-GATOR2 interaction and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo